Icecure Medical

Icecure Medical EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Icecure Medical (ICCM) as of Oct 22, 2026 is -15.70 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -15.58 M USD — a change of 0.77% (lower).

EBITDA

-15.70 MUSD

YoY

0.77%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Icecure Medical is 2024 -15.70 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Icecure Medical was 2023 -15.58 M USD. It decreases by 0.77% lower compared to the previous year.

The Icecure Medical EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2017
-2.57 M USD
Jan 1, 2018
-3.31 M USD
Jan 1, 2019
-4.40 M USD
Jan 1, 2020
-4.14 M USD
Jan 1, 2021
-9.72 M USD
Jan 1, 2022
-16.74 M USD
Jan 1, 2023
-15.58 M USD
Jan 1, 2024
-15.70 M USD
The Icecure Medical EBITDA history
YEAREBITDAYoY
-15.70 MUSD+0.77%
-15.58 MUSD-6.95%
-16.74 MUSD+72.22%
-9.72 MUSD+134.78%
-4.14 MUSD-5.91%
-4.40 MUSD+32.93%
-3.31 MUSD+28.79%
-2.57 MUSD-17.10%
-3.10 MUSD-12.43%
-3.54 MUSD-20.27%
-4.44 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Icecure Medical Stock analysis

What does Icecure Medical do? Icecure Medical Ltd., based in Caesarea, Israel, is a commercial-stage medical device company specializing in cryoablation systems for tumor treatment. The company develops and markets liquid nitrogen-based technologies, including the ProSense single-probe system and the non-commercialized MultiSense multi-probe system, offering minimally invasive alternatives to surgery for tumors in breast, lung, kidney, and bone tissues. With 65 employees, it has been listed since February 2011. Icecure Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Icecure Medical stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Icecure Medical is -15.70 M USD in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Icecure Medical changed from -15.58 M USD to -15.70 M USD, representing a 0.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Icecure Medical since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Icecure Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Icecure Medical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Icecure Medical